期刊文献+

热疗降低胶质瘤侵袭性的作用与TNF-α和Cx-43的关系 被引量:2

Relation between hyperthermia reduce glioma invasiveness and changes of TNF-α and Cx-43
下载PDF
导出
摘要 目的:探讨热疗诱发胶质瘤细胞释放的肿瘤坏死因子-α(TNF-α)对胶质瘤细胞侵袭性的影响机制。方法:热处理C6细胞后,应用放射免疫法动态监测培养液内TNF-α的含量;观察热处理C6细胞后的条件培养液(C6CM)对胶质瘤细胞内的丝裂素活化蛋白激酶(mitogen-activated protein kinase,MAPK)mRNA的转录水平、NF-κB含量及胶质瘤侵袭性的影响;利用免疫荧光技术检测C6CM对体外胶质瘤侵袭模型上连接蛋白Cx-43表达的影响。结果:热处理C6细胞后,培养液内TNF-α的含量增加,于120 min时达高峰。C6CM作用于体外胶质瘤侵袭模型后,胶质瘤细胞的MAPK mRNA转录水平及NF-κB含量增加,且均于第120 min时达最高水平。与此同时,体外胶质瘤细胞的连接蛋白Cx-43表达水平也呈相同的变化趋势。结论:热疗可诱发C6细胞释放TNF-α,其可能是通过增加胶质瘤细胞的MAPK mRNA转录水平和NF-κB的含量而导致胶质瘤细胞的连接蛋白Cx-43的表达增加,进而引起胶质瘤侵袭性降低的。 Objective:To assess the effect and mechanism of tumor necrosis factor-α(TNF-α) induced by hyperthermia from glioma cells to glioma invasiveness.Methods: We used radioimmunoassay to dynamically monitor contents of TNF-α in nutrient fluid for C6 cells after hyperthermia treatment.The effects of conditioned medium of C6(C6CM) treated by hyperthermiaon on levels of mitogen-activated protein kinase(MAPK) mRNA and contents of nuclear transcription factor kappaB(NF-κB) in glioma cells,as well as glioma invasiveness.By using immunofluorescence technique,the effects of C6CM on the expression of Cx-43 in glioma cells.Results: Contents of TNF-α in the nutrient fluid for C6 cells increased obviously after hyperthermia treatment and achieved the maximal level at 120 min.After adding C6CM in vitro glioma invasiveness model,levels of MAPK mRNA and contents of NF-κB were both increased,reached the maximum level at 120 min.And the expression of Cx-43 showed the same trend.Conclusion: Hyperthermia promoted C6 cells to release TNF-α.The TNF-α increased the expression of NF-κB and levels of MAPK mRNA in C6 cells,then enhanced expression of Cx-43,which decreased glioma invasiveness.
出处 《神经解剖学杂志》 CAS CSCD 北大核心 2012年第3期268-272,共5页 Chinese Journal of Neuroanatomy
基金 河北省卫生厅科研基金项目(20100464,20110165) 唐山市科学技术研究与发展计划项目(111302048b) 河北联合大学大学生创新性实验计划项目(X2011035) 河北联合大学博士启动基金项目(BS09012)
关键词 热疗 肿瘤坏死因子-Α 连接蛋白-43 肿瘤侵袭性 hyperthermia tumor necrosis factor-α connexin-43 tumor invasiveness
  • 相关文献

参考文献2

二级参考文献22

  • 1Rice C, Halfpenny C, Scolding N. Cell therapy in demyelinating diseases[J].NeuroRX, 2004, 1 : 415 -423.
  • 2Pazour J, Mokry J. Stem cell therapy for demyelinating disorders [J]. Acta Medica (Hradec Kralove) , 2006, 49:79-85.
  • 3Cummings B J, Uehida N, Tamaki SJ, et al. Human neural stem cells differentiate and promote locomotor reeovery in spinal cord-injured miee[Jl. Proe Natl Aead Sci USA, 2005, 102:14069 - 14074.
  • 4Ziv Y, Avidan H, Pluchino S, et al. Synergy between immune cells and adult neural stern/progenitor cells promotes functional recovery. from spinal cord injury[J]. Proc Natl Acad Sci USA, 2006, 103: 13174 - 13179.
  • 5Cao QL, Zhang YP, Howard RM, et al. Pluripotent stem cells engrafted into the normal or lesioned adult rat spinal cord are restricted to a glial lineage [ J ]. Exp Neurol, 2001, 167 : 48 - 58.
  • 6Ricci-Vitiani L, Casalbore P, Petrucci G, et al. Influence of local environment on the differentiation of neural stem cells engrafted onto the injured spinal cord[ J]. Neurol Res, 2006, 28: 488- 492.
  • 7Takebayashi H, Yoshida S, Sugimori M,et al. Dynamic expression of basic helix-loop-helix Olig family members: implication of Olig2 in neuron and oligodendrocyte differentiation and identification of a new member, Olig3[Jl. Mech Dev, 2000, 99:143 -148.
  • 8Lu QR, Sun T, Zhu Z,et al. Common developmental requirement for Olig function indicates a motor neuron/oligodendrocyte connection[J]. Cell, 2002, 109:75-86.
  • 9Ligon KL, Fancy SP, Franklin R J, et al. Olig gene function in CNS development and disease[Jl. Glia, 2006, 54:1 -10.
  • 10Copray S, Balasubramaniyan V, Levenga J, et al. Olig2 overexpression induces the in vitro differentiation of neural stem cells into mature oligodendrocytes[ J ]. Stem Cells, 2006,24 : 1001 - 1010.

共引文献8

同被引文献24

  • 1E1 Hindy N, Bankfalvi A, Herring A, et al. Correlation of aquapor- in-1 water channel protein expression with tumor angiogenesis in hu- man astrocytoma[ J]. Anticancer Res, 2013, 33:609 -613.
  • 2Tyrinova TV, Leplina OY, Mishinov SV, et al. Cytotoxic activity of ex-vivo generated IFNct-induced monocyte-derived dendritic cells in brain glioma patients[ J]. Cell Immunol, 2013, 284 : 146 - 153.
  • 3Patil SA, Hosni-Ahmed A, Jones "IS, et al. Novel approaches to gli- oma drug design and drug screening[ J]. Expert Opin Drug Discov, 2013, 8:1135-1151.
  • 4Jiang H, Wang C, Guo Z, et al. Silver nanocrystals mediated com- bination therapy of radiation with magnetic hyperthermia on glioma ceils [ J ]. J Nanosci Nanotechnol, 2012, 12:8276 - 8281.
  • 5Sahebjam S, Garoufalis E, Guiot MC, et al. Bevacizumab use for recurrent high-grade glioma at McGill University Hospital [ J ]. Can J Neurol Sci, 2013, 40:241 -246.
  • 6Dahlrot RH, Hermansen SK, Hansen S, et al. What is the clinical value of cancer stem cell markers in gliomas [ J ]. Int J Clin Exp Pathol, 2013, 6:334 - 348.
  • 7Hasday JD, Fairchild KD, Shanhohz C. The role of fever in the infec- ted host [J]. Microbes Infect, 2000, 2:1891 -1904.
  • 8Franke K, Kettering M, Lange K, et al. The exposure of cancer ceils to hyperthermia, iron oxide nanoparticles, and mitomycin C influences membrane multidrug resistance protein expression levels [J]. Int J Nanomedicine, 2013, 8:351 -363.
  • 9Takeda T, Kobayashi S, Kobayashi. Immunotherapy with hyper- thermia for advanced or recurrent breast cancer patients in whom standard therapy showed no effect or was refused [ J ]. Gan To Ka- gaku Ryoho, 2012, 39:1766-1769.
  • 10Tsehoep-Lechner KE, Milani V, Berger F, et al. Gemcitabine and cisplatin combined with regional hyperthermia as second-line treat- ment in patients with gemcitabine-refractory advanced pancreatic cancer [ J ]. Int J Hyperthermia, 2013, 29:8 - 16.

引证文献2

二级引证文献22

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部